Icu Medical (ICUI) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $162.99, -2.54% vs the prior close of $167.23.
- Volume 221.67K shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ICUI dips 2.5% to $162.99. Closed at $162.99, -2.54% vs the prior close of $167.23. Day range $162.51–$167.70, opened at $167.30.
ICUI daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ICUI dips 2.5% to $162.99
- Closed at $162.99, -2.54% vs the prior close of $167.23. Day range $162.51–$167.70, opened at $167.30.
- Volume was 221.67K shares, 0.8x its 50-day average of 261.64K.
- Price is -2.9% vs its 50-day average ($167.91) and +10.3% vs its 200-day average ($147.76).
- 52-week range $113.37–$192.85; today's close sits at 62% of that range, 15.5% below the 52-week high.
Oct 15, 2026 — ICUI rises 2.8% to $167.23, a 1-month high
- Closed at $167.23, +2.79% vs the prior close of $162.69. Day range $164.10–$167.73, opened at $164.10.
- Volume was 239.50K shares, 0.9x its 50-day average of 263.37K.
- Price is -0.4% vs its 50-day average ($167.98) and +13.2% vs its 200-day average ($147.67).
- 52-week range $113.37–$192.85; today's close sits at 68% of that range, 13.3% below the 52-week high.
Oct 14, 2026 — ICUI dips 0.3% to $162.69
- Closed at $162.69, -0.33% vs the prior close of $163.23. Day range $161.64–$163.87, opened at $162.20.
- Volume was 258.40K shares, 1.0x its 50-day average of 264.61K.
- Price is -3.1% vs its 50-day average ($167.96) and +10.2% vs its 200-day average ($147.57).
- 52-week range $113.37–$192.85; today's close sits at 62% of that range, 15.6% below the 52-week high.
Oct 13, 2026 — ICUI dips 0.4% to $163.23
- Closed at $163.23, -0.41% vs the prior close of $163.91. Day range $162.99–$167.05, opened at $165.16.
- Volume was 236.30K shares, 0.9x its 50-day average of 271.47K.
- Price is -2.9% vs its 50-day average ($168.15) and +10.7% vs its 200-day average ($147.49).
- 52-week range $113.37–$192.85; today's close sits at 63% of that range, 15.4% below the 52-week high.
Oct 12, 2026 — ICUI rises 2.2% to $163.91, 3 up days in a row
- Closed at $163.91, +2.24% vs the prior close of $160.32. Day range $159.50–$164.40, opened at $159.73.
- Volume was 201.40K shares, 0.7x its 50-day average of 274.44K.
- Price is -2.6% vs its 50-day average ($168.34) and +11.2% vs its 200-day average ($147.41).
- 52-week range $112.50–$192.85; today's close sits at 64% of that range, 15.0% below the 52-week high.
- That makes 3 straight gains.
Oct 9, 2026 — ICUI rises 2.0% to $160.32
- Closed at $160.32, +2.00% vs the prior close of $157.18. Day range $157.46–$160.47, opened at $157.46.
- Volume was 146.00K shares, 0.5x its 50-day average of 279.60K — lighter than usual.
- Price is -4.8% vs its 50-day average ($168.43) and +8.8% vs its 200-day average ($147.33).
- 52-week range $112.50–$192.85; today's close sits at 60% of that range, 16.9% below the 52-week high.
Oct 8, 2026 — ICUI rises 0.7% to $157.18
- Closed at $157.18, +0.74% vs the prior close of $156.03. Day range $153.33–$157.50, opened at $154.81.
- Volume was 220.60K shares, 0.8x its 50-day average of 281.25K.
- Price is -6.8% vs its 50-day average ($168.59) and +6.7% vs its 200-day average ($147.27).
- 52-week range $112.50–$192.85; today's close sits at 56% of that range, 18.5% below the 52-week high.
Oct 7, 2026 — ICUI dips 2.3% to $156.03
- Closed at $156.03, -2.32% vs the prior close of $159.73. Day range $155.54–$160.50, opened at $157.89.
- Volume was 214.60K shares, 0.8x its 50-day average of 281.76K.
- Price is -7.6% vs its 50-day average ($168.78) and +6.0% vs its 200-day average ($147.21).
- 52-week range $112.50–$192.85; today's close sits at 54% of that range, 19.1% below the 52-week high.
Oct 6, 2026 — ICUI dips 1.0% to $159.73
- Closed at $159.73, -1.03% vs the prior close of $161.40. Day range $157.65–$162.55, opened at $162.55.
- Volume was 238.60K shares, 0.8x its 50-day average of 284.26K.
- Price is -5.5% vs its 50-day average ($168.98) and +8.5% vs its 200-day average ($147.16).
- 52-week range $112.50–$192.85; today's close sits at 59% of that range, 17.2% below the 52-week high.
Oct 5, 2026 — ICUI rises 1.3% to $161.40
- Closed at $161.40, +1.27% vs the prior close of $159.38. Day range $157.80–$162.81, opened at $159.35.
- Volume was 211.50K shares, 0.7x its 50-day average of 285.20K.
- Price is -4.5% vs its 50-day average ($169.01) and +9.7% vs its 200-day average ($147.09).
- 52-week range $112.50–$192.85; today's close sits at 61% of that range, 16.3% below the 52-week high.
Oct 2, 2026 — ICUI rises 1.4% to $159.38
- Closed at $159.38, +1.40% vs the prior close of $157.18. Day range $157.15–$161.33, opened at $158.78.
- Volume was 227.70K shares, 0.8x its 50-day average of 287.58K.
- Price is -5.7% vs its 50-day average ($168.93) and +8.4% vs its 200-day average ($147.02).
- 52-week range $112.50–$192.85; today's close sits at 58% of that range, 17.4% below the 52-week high.
ICUI latest news & SEC filings
Every SEC filing by or about ICUI in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Sanzone Virginia Ruth sold 2,202 shares at $167.67 (≈$369.21K) on Sep 3, 2026
- Sanzone Virginia Ruth sold 692 shares at $171.52 (≈$118.69K) on Sep 3, 2026
- Sanzone Virginia Ruth sold 724 shares at $169.53 (≈$122.74K) on Sep 3, 2026
- Sanzone Virginia Ruth sold 1,238 shares at $168.44 (≈$208.53K) on Sep 3, 2026
- Sanzone Virginia Ruth sold 2,202 shares at $167.67 (≈$369.21K) on Sep 3, 2026
- Sanzone Virginia Ruth sold 692 shares at $171.52 (≈$118.69K) on Sep 3, 2026
- …plus 10 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 3, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Bonnell Brian Michael sold 6,381 shares at $175.00 (≈$1.12M) on Sep 1, 2026
- Bonnell Brian Michael sold 6,381 shares at $175.00 (≈$1.12M) on Sep 1, 2026
- Bonnell Brian Michael sold 6,381 shares at $175.00 (≈$1.12M) on Sep 1, 2026
- Bonnell Brian Michael sold 6,381 shares at $175.00 (≈$1.12M) on Sep 1, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 1, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 31, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Bonnell Brian Michael sold 1,113 shares at $173.91 (≈$193.56K) on Aug 31, 2026
- Bonnell Brian Michael sold 1,914 shares at $172.12 (≈$329.44K) on Aug 31, 2026
- Bonnell Brian Michael sold 1,712 shares at $171.05 (≈$292.84K) on Aug 31, 2026
- Bonnell Brian Michael sold 4,568 shares at $173.44 (≈$792.27K) on Aug 31, 2026
- Bonnell Brian Michael sold 1,113 shares at $173.91 (≈$193.56K) on Aug 31, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 31, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $551.68M (prior year $548.87M) (+0.5% vs Jun 30, 2025)
- Net income: $19.09M (prior year $35.34M) (-46.0% vs Jun 30, 2025)
- Diluted EPS: $0.76 (prior year $1.43) (-46.9% vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade ICUI
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Feb 19, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.55% (largest 3.7%).
- Liquidity: about 249.88K shares (≈$40.73M) trade per day on average.
- 52-week position: $162.99 vs a range of $113.37–$192.85 (62% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Virginia Ruth Sanzone sold 2,202 shares on Sep 3, 2026.
- Latest filings: 10-Q Aug 6, 2026; 8-K Aug 6, 2026; 8-K May 18, 2026.
- Share count: 25.01M shares outstanding (Jul 31, 2026), +1.3% vs a year earlier.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
ICUI market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 167.30 | 167.70 | 162.51 | 162.99 | 221.67K |
| Oct 15, 2026 | 164.10 | 167.73 | 164.10 | 167.23 | 239.50K |
| Oct 14, 2026 | 162.20 | 163.87 | 161.64 | 162.69 | 258.40K |
| Oct 13, 2026 | 165.16 | 167.05 | 162.99 | 163.23 | 236.30K |
| Oct 12, 2026 | 159.73 | 164.40 | 159.50 | 163.91 | 201.40K |
| Oct 9, 2026 | 157.46 | 160.47 | 157.46 | 160.32 | 146.00K |
| Oct 8, 2026 | 154.81 | 157.50 | 153.33 | 157.18 | 220.60K |
| Oct 7, 2026 | 157.89 | 160.50 | 155.54 | 156.03 | 214.60K |
| Oct 6, 2026 | 162.55 | 162.55 | 157.65 | 159.73 | 238.60K |
| Oct 5, 2026 | 159.35 | 162.81 | 157.80 | 161.40 | 211.50K |
| Oct 2, 2026 | 158.78 | 161.33 | 157.15 | 159.38 | 227.70K |
| Oct 1, 2026 | 160.08 | 161.55 | 156.91 | 157.18 | 248.20K |
| Sep 30, 2026 | 163.64 | 164.55 | 159.84 | 160.51 | 307.20K |
| Sep 29, 2026 | 163.92 | 164.35 | 161.44 | 163.44 | 245.90K |
| Sep 28, 2026 | 163.97 | 166.71 | 163.05 | 164.03 | 290.60K |
| Sep 25, 2026 | 166.43 | 166.67 | 163.95 | 164.95 | 201.70K |
| Sep 24, 2026 | 163.12 | 167.67 | 163.08 | 166.02 | 380.10K |
| Sep 23, 2026 | 160.26 | 166.46 | 159.29 | 163.32 | 408.30K |
| Sep 22, 2026 | 157.64 | 163.57 | 156.01 | 160.98 | 276.00K |
| Sep 21, 2026 | 154.25 | 156.80 | 152.49 | 155.22 | 223.40K |
About Icu Medical
Icu Medical (ICUI) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in SAN CLEMENTE, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 883984.
ICUI board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Donald Abbey | Director | May 13, 2026 |
| Elisha W Finney | Director | Aug 11, 2026 |
| David C. Greenberg | Director | May 13, 2026 |
| Laurie Hernandez | Director | May 13, 2026 |
| David F Hoffmeister | Director | May 13, 2026 |
| Vivek Jain | Chairman and CEO | Mar 16, 2026 |
| Kolleen T Kennedy | Director | May 13, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Brian Michael Bonnell | Chief Financial Officer | Sep 1, 2026 |
| Vivek Jain | Chairman and CEO | Mar 16, 2026 |
| Virginia Ruth Sanzone | VP, General Counsel | Sep 3, 2026 |
| Ben Sousa | Chief Information Officer | Aug 12, 2026 |
| Christian B. Voigtlander | Chief Operating Officer | Aug 11, 2026 |
| Daniel Woolson | VP, GM-Infusion Capital | Aug 13, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 3, 2026 | Virginia Ruth Sanzone | Sale | 2,202 | $167.67 |
| Sep 3, 2026 | Virginia Ruth Sanzone | Sale | 692 | $171.52 |
| Sep 3, 2026 | Virginia Ruth Sanzone | Sale | 724 | $169.53 |
| Sep 3, 2026 | Virginia Ruth Sanzone | Sale | 1,238 | $168.44 |
| Sep 3, 2026 | Virginia Ruth Sanzone | Sale | 2,202 | $167.67 |
| Sep 3, 2026 | Virginia Ruth Sanzone | Sale | 692 | $171.52 |
| Sep 3, 2026 | Virginia Ruth Sanzone | Sale | 724 | $169.53 |
| Sep 3, 2026 | Virginia Ruth Sanzone | Sale | 1,238 | $168.44 |
| Sep 3, 2026 | Virginia Ruth Sanzone | Sale | 2,202 | $167.67 |
| Sep 3, 2026 | Virginia Ruth Sanzone | Sale | 692 | $171.52 |
| Sep 3, 2026 | Virginia Ruth Sanzone | Sale | 724 | $169.53 |
| Sep 3, 2026 | Virginia Ruth Sanzone | Sale | 1,238 | $168.44 |
| Sep 3, 2026 | Virginia Ruth Sanzone | Sale | 2,202 | $167.67 |
| Sep 3, 2026 | Virginia Ruth Sanzone | Sale | 692 | $171.52 |
| Sep 3, 2026 | Virginia Ruth Sanzone | Sale | 724 | $169.53 |
ICUI financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $2.23B | $732.00K | 0.03 | $179.85M |
| Dec 31, 2024 | $2.38B | $-117.69M | -4.83 | $204.03M |
| Dec 31, 2023 | $2.26B | $-29.66M | -1.23 | $166.20M |
| Dec 31, 2022 | $2.28B | $-74.29M | -3.11 | $-62.13M |
| Dec 31, 2021 | $1.32B | $103.14M | 4.74 | $267.54M |
Latest balance sheet: total assets $3.97B, total liabilities $—, cash $208.78M (as of Jun 30, 2026).
ICUI earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $166.37 |
| May 7, 2026 | 8-K Item 2.02 (results) | $123.07 |
| Feb 19, 2026 | 8-K Item 2.02 (results) | $149.74 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $129.67 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $129.91 |
| May 8, 2025 | 8-K Item 2.02 (results) | $142.87 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $149.75 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $178.01 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
| Feb 27, 2024 | 8-K Item 2.02 (results) | — |
| Nov 6, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ICUI
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.